Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botox therapy for refractory chronic migraine.

Stafford Conway1, Curtis Delplanche, Jessica Crowder

  • 1University of South Alabama Headache Center, Mobile, AL 36693, USA.

Headache
|April 20, 2005
PubMed
Summary

Botulinum toxin type A injections offer a safe and useful treatment option for chronic migraine patients who have not responded to other medications. This therapy provides a new avenue for managing difficult-to-treat chronic migraine cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.

Cephalalgia : an international journal of headache·2026
Same author

Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi-center study.

Headache·2022
Same author

Triptans for Migraine Patients With Vascular Risks: New Insights, New Options.

Headache·2019
Same author

Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.

Headache·2019
Same author

An analysis of migraine triggers in a clinic-based population.

Headache·2010
Same author

Suboccipital nerve blocks for suppression of chronic migraine: safety, efficacy, and predictors of outcome.

Headache·2010

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Chronic migraine is a prevalent and debilitating neurological condition.
  • Many patients with chronic migraine do not respond adequately to standard prophylactic medications.
  • Treatment resistance poses a significant challenge in managing chronic migraine.

Purpose of the Study:

  • To evaluate the safety and utility of botulinum toxin type A injection therapy.
  • To assess the effectiveness of botulinum toxin type A in patients with chronic migraine.
  • To investigate a treatment option for chronic migraine refractory to multiple prophylactic medications.

Main Methods:

  • An open-label study design was employed.
  • Botulinum toxin type A injections were administered to patients with chronic migraine.

Related Experiment Videos

  • Patient outcomes were assessed for safety and utility.

    • Main Results:

    • Botulinum toxin type A injections demonstrated safety in the studied patient group.
    • The therapy showed utility for patients with chronic migraine.
    • Effectiveness in patients refractory to prior treatments was observed.

    Conclusions:

    • Botulinum toxin type A is a safe and useful therapeutic option for chronic migraine.
    • This treatment can be beneficial for patients with treatment-resistant chronic migraine.
    • Further research may explore long-term efficacy and optimal dosing.